Impact of Absolute Lymphocyte Count at Time of Antithymocyte Globulin on Outcomes of Allogeneic Unrelated Hematopoietic Cell Transplantation with Busulfan and Fludarabine Myeloablative Conditioning

被引：0
|
作者：
Chennamadhavuni, Adithya [1 ]
Nadiminti, Kalyan [2 ]
Dozeman, Lindsay [3 ]
Farooq, Umar [4 ]
Jethava, Yogesh [4 ]
Mott, Sarah [5 ]
Silverman, Margarida Magalhaes [3 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Mayo Clin, Hematol, Rochester, MN USA
[3] Univ Iowa Hosp & Clin, Div Hematol Oncol Blood & Marrow Transplantat, Iowa City, IA 52242 USA
[4] Univ Iowa, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA USA
[5] Holden Comprehens Canc Ctr, Iowa City, IA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5671
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [22] Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
    J De La Serna
    J Sanz
    A Bermúdez
    M Cabrero
    D Serrano
    C Vallejo
    V Gómez
    J M Moraleda
    S G Perez
    M D Caballero
    E Conde
    J J Lahuerta
    G Sanz
    Bone Marrow Transplantation, 2016, 51 : 961 - 966
  • [23] Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
    De La Serna, J.
    Sanz, J.
    Bermudez, A.
    Cabrero, M.
    Serrano, D.
    Vallejo, C.
    Gomez, V.
    Moraleda, J. M.
    Perez, S. G.
    Caballero, M. D.
    Conde, E.
    Lahuerta, J. J.
    Sanz, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 961 - 966
  • [24] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [25] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [26] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
    Bornhäuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    Martin, PJ
    McDonald, GB
    Nichols, WG
    Radich, J
    Woolfrey, A
    Jenke, A
    Schleyer, E
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2003, 102 (03) : 820 - 826
  • [27] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Different Doses of Antithymocyte Globulin Containing Conditioning in Hematological Malignancies
    Gokgoz, Zafer
    Soydan, Ender
    Gokmen, Ayla
    Arslan, Onder
    Ilhan, Osman
    Ozcan, Muhit
    BONE MARROW TRANSPLANTATION, 2018, 53 : 284 - 285
  • [28] Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non-Hodgkin Lymphoma
    Ayala, Ernesto
    Figueroa, Javier
    Perkins, Janelle
    Kim, Jongphil
    Yue, Binglin
    Riches, Marcie
    Nishihori, Taiga
    Locke, Frederick
    Anasetti, Claudio
    Kharfan-Dabaja, Mohamed A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06): : 335 - 340
  • [29] Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies
    Connor, Matthew P.
    Loren, Alison W.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    Gill, Saar I.
    Luger, Selina M.
    Mangan, James K.
    Perl, Alexander E.
    McCurdy, Shannon R.
    Pratz, Keith W.
    Timlin, Colleen
    Freyer, Craig W.
    Carulli, Alison
    Catania, Christopher
    Smith, Jacqueline
    Hollander, Lauren
    Zebrowski, Alexis M.
    Stadtmauer, Edward A.
    Porter, David L.
    Frey, Noelle, V
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 113 - 118
  • [30] Busulfan-Dependent Hepatotoxicity of Antithymocyte Globulin Formulations During Conditioning for Hematopoietic Stem Cell Transplantation
    van der Velden, Walter J. F. M.
    de Weerd-de Jong, Esther C.
    de Haan, Anton F. J.
    Blijlevens, Nicole M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) : 410 - 412
12345